Owens-Illinois (NYSE:OI) was upgraded by Goldman Sachs (NYSE:GS) to buy with a price target of $28, as the new CFO has been improving the capital allocation strategy of the company.
Shares are higher by about 4.6 percent.
Impax Labs (NASDAQ:IPXL) had its number raised by Bank of America/Merrill Lynch (NYSE:BAC) as the company has been seeing higher sales of its generic drugs. An underperform rating was issued with a $25 price target.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.